[
  {
    "ts": null,
    "headline": "Stock Market Today: Dow Slips Back Below 49K; Trump Takes On Defense Firms (Live Coverage)",
    "summary": "The Dow Jones index dipped in mixed trade Wednesday after surprise jobs data. Bitcoin stock Strategy jumped.",
    "url": "https://finnhub.io/api/news?id=00d24019bb03f34368b23194b5fc40d1aebfe34ff3a9cb9bd6853ed1cbffe1fa",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767823943,
      "headline": "Stock Market Today: Dow Slips Back Below 49K; Trump Takes On Defense Firms (Live Coverage)",
      "id": 138032848,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "The Dow Jones index dipped in mixed trade Wednesday after surprise jobs data. Bitcoin stock Strategy jumped.",
      "url": "https://finnhub.io/api/news?id=00d24019bb03f34368b23194b5fc40d1aebfe34ff3a9cb9bd6853ed1cbffe1fa"
    }
  },
  {
    "ts": null,
    "headline": "S&P 500, Dow Jones Slid From Peaks Amid Sell-Off in Old Economy Sectors, Mounting Geopolitical Crisis",
    "summary": "US equity indexes closed mixed on Wednesday, with the S&P 500 and the Dow Jones Industrial Average r",
    "url": "https://finnhub.io/api/news?id=38558d276be5a29ce4312eef987aaaf167632e68a80d803eb4b0b4346318ad99",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767823927,
      "headline": "S&P 500, Dow Jones Slid From Peaks Amid Sell-Off in Old Economy Sectors, Mounting Geopolitical Crisis",
      "id": 138033017,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "US equity indexes closed mixed on Wednesday, with the S&P 500 and the Dow Jones Industrial Average r",
      "url": "https://finnhub.io/api/news?id=38558d276be5a29ce4312eef987aaaf167632e68a80d803eb4b0b4346318ad99"
    }
  },
  {
    "ts": null,
    "headline": "AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE",
    "summary": "Amgen (NASDAQ:AMGN) will present at the 2026 J.P. Morgan Healthcare Conference at 3:45 p.m. PT on Monday, January 12, 2026. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.",
    "url": "https://finnhub.io/api/news?id=b706d451590ef9e5b468a0a0e38c4e8554bc7c109d45d3bb20b2031ffcf36a1b",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767819660,
      "headline": "AMGEN TO PRESENT AT THE 44TH ANNUAL J.P. MORGAN HEALTHCARE CONFERENCE",
      "id": 138033314,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Amgen (NASDAQ:AMGN) will present at the 2026 J.P. Morgan Healthcare Conference at 3:45 p.m. PT on Monday, January 12, 2026. Robert A. Bradway, chairman and chief executive officer at Amgen, will present at the conference. The webcast will be broadcast over the internet simultaneously and will be available to members of the news media, investors and the general public.",
      "url": "https://finnhub.io/api/news?id=b706d451590ef9e5b468a0a0e38c4e8554bc7c109d45d3bb20b2031ffcf36a1b"
    }
  },
  {
    "ts": null,
    "headline": "ALMS Surges as Envudeucitinib Meets Goals in Plaque Psoriasis Studies",
    "summary": "Alumis shares jump 95% after envudeucitinib meets all endpoints in two phase III plaque psoriasis studies, showing strong skin clearance.",
    "url": "https://finnhub.io/api/news?id=29e6f6561909fbf0b2c0dc028a2550561913d05d7bc4f855dfc8b1c6e524906c",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767804720,
      "headline": "ALMS Surges as Envudeucitinib Meets Goals in Plaque Psoriasis Studies",
      "id": 138033316,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Alumis shares jump 95% after envudeucitinib meets all endpoints in two phase III plaque psoriasis studies, showing strong skin clearance.",
      "url": "https://finnhub.io/api/news?id=29e6f6561909fbf0b2c0dc028a2550561913d05d7bc4f855dfc8b1c6e524906c"
    }
  },
  {
    "ts": null,
    "headline": "Amgen buys Dark Blue Therapeutics in $840m oncology deal",
    "summary": "According to Citi analysts, Amgen’s acquisition of Dark Blue could further drive the strength of Amgen’s early oncology pipeline.",
    "url": "https://finnhub.io/api/news?id=82e1b77ea63d99157339469b46db2610935f12d080b5a68072a3ebda2bc72c5d",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767790247,
      "headline": "Amgen buys Dark Blue Therapeutics in $840m oncology deal",
      "id": 138027218,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "According to Citi analysts, Amgen’s acquisition of Dark Blue could further drive the strength of Amgen’s early oncology pipeline.",
      "url": "https://finnhub.io/api/news?id=82e1b77ea63d99157339469b46db2610935f12d080b5a68072a3ebda2bc72c5d"
    }
  },
  {
    "ts": null,
    "headline": "Stocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more",
    "summary": "Check out some of the biggest movers in midday trading.",
    "url": "https://finnhub.io/api/news?id=c89cdc3e4b6bb7beb5c966a3d602f82319b80feab433f7d34df14831de8c38ac",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767788408,
      "headline": "Stocks making the biggest moves midday: Deckers Outdoor, Amgen, Western Digital, Ventyx Biosciences & more",
      "id": 138028002,
      "image": "https://image.cnbcfm.com/api/v1/image/107419799-1716556047925-gettyimages-1246717795-porzycki-polandsn230201_npl09.jpeg?v=1767805826&w=1920&h=1080",
      "related": "AMGN",
      "source": "CNBC",
      "summary": "Check out some of the biggest movers in midday trading.",
      "url": "https://finnhub.io/api/news?id=c89cdc3e4b6bb7beb5c966a3d602f82319b80feab433f7d34df14831de8c38ac"
    }
  },
  {
    "ts": null,
    "headline": "DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies",
    "summary": "Collaboration with Amgen to advance a cancer target discovered using DISCO’s proprietary surfaceome mapping technology Cologne, Germany, January 7, 2026 – DISCO Pharmaceuticals (“DISCO”), today announced an exclusive license agreement with Amgen to advance novel therapeutic candidates addressing a target that was mapped on the surface of a cancer cell by DISCO’s proprietary platform. Under the terms of the agreement, DISCO will be eligible to receive up to $618 million total potential deal value",
    "url": "https://finnhub.io/api/news?id=0f5caff107c40dcecba67b7fbf71471f8f059be3fc2b330c63968d3af302c155",
    "source": "Yahoo",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767780000,
      "headline": "DISCO Pharmaceuticals Enters License Agreement to Advance Novel Cancer Surfaceome Targeted Therapies",
      "id": 138025882,
      "image": "https://s.yimg.com/rz/stage/p/yahoo_finance_en-US_h_p_finance_2.png",
      "related": "AMGN",
      "source": "Yahoo",
      "summary": "Collaboration with Amgen to advance a cancer target discovered using DISCO’s proprietary surfaceome mapping technology Cologne, Germany, January 7, 2026 – DISCO Pharmaceuticals (“DISCO”), today announced an exclusive license agreement with Amgen to advance novel therapeutic candidates addressing a target that was mapped on the surface of a cancer cell by DISCO’s proprietary platform. Under the terms of the agreement, DISCO will be eligible to receive up to $618 million total potential deal value",
      "url": "https://finnhub.io/api/news?id=0f5caff107c40dcecba67b7fbf71471f8f059be3fc2b330c63968d3af302c155"
    }
  },
  {
    "ts": null,
    "headline": "Jim Cramer's top 10 things to watch in the stock market Wednesday",
    "summary": "The stock market was little changed this morning after the S&P 500 hit records highs Tuesday.",
    "url": "https://finnhub.io/api/news?id=a57b975de029806c09eb01c4b7ec39385868263fc9dfb7e3d6ee1aa602c63b5b",
    "source": "CNBC",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1767777423,
      "headline": "Jim Cramer's top 10 things to watch in the stock market Wednesday",
      "id": 138027947,
      "image": "https://image.cnbcfm.com/api/v1/image/107200469-1677528554271-NUP_200782_00155.jpg?v=1721682202&w=1920&h=1080",
      "related": "AMGN",
      "source": "CNBC",
      "summary": "The stock market was little changed this morning after the S&P 500 hit records highs Tuesday.",
      "url": "https://finnhub.io/api/news?id=a57b975de029806c09eb01c4b7ec39385868263fc9dfb7e3d6ee1aa602c63b5b"
    }
  }
]